IRF5 and systemic lupus erythematosus: Although our EWAS did not focus on the study of SLE patients, small effects of IRF5 methylation on kidney-related outcomes, mediated at least partially by its expression and subsequent IFN pathways, might be detected as effects on eGFR in the general population.